FrancophonIA/ELRC3.0 huggingface dataset:
English: The Xoterna Breezhaler clinical Phase III development programme included six studies in which over 8,000 patients were enrolled: 1) a 26-week placebo- and active-controlled (indacaterol once daily, glycopyrronium once daily, open-label tiotropium once daily) study; 2) a 26-week active-controlled (fluticasone/salmeterol twice daily) study; 3) a 64-week active-controlled (glycopyrronium once daily, open-label tiotropium once daily) study; 4) a 52-week placebo-controlled study; 5) a 3-week placeboand active-controlled (tiotropium once daily) exercise tolerance study; and 6) a 52-week activecontrolled (fluticasone/salmeterol twice daily) study.
Croatian: Klinički razvojni program faze III za Xoterna Breezhaler uključivao je šest ispitivanja u koje je bilo uključeno više od 8000 bolesnika: 1) 26-tjedno placebom i aktivno kontrolirano (indakaterol jedanput na dan, glikopironij jedanput na dan, nemaskirani tiotropij jedanput na dan) ispitivanje; 2) 26-tjedno aktivno kontrolirano (flutikazon/salmeterol dvaput na dan) ispitivanje; 3)
English: How to store Xoterna Breezhaler Contents of the pack and other information Instructions for use of Xoterna Breezhaler inhaler
Croatian: Sadržaj pakiranja i druge informacije Upute za primjenu Xoterna Breezhaler inhalatora
English: A higher percentage of patients receiving Xoterna Breezhaler responded with a clinically meaningful improvement in SGRQ score (defined as a decrease of at least 4 units from baseline) at week 26 compared to placebo (63.7% and 56.6% respectively, p=0.088) and tiotropium (63.7% Xoterna Breezhaler vs. 56.4% tiotropium, p=0.047), at week 64 compared to glycopyrronium and tiotropium (57.3% Xoterna Breezhaler versus 51.8% glycopyrronium, p=0.055; versus 50.8% tiotropium, p=0.051, respectively) and at week 52 compared to fluticasone/salmeterol (49.2% Xoterna Breezhaler vs. 43.7% fluticasone/salmeterol, odds ratio: 1.30, p<0.001).
Croatian: Viši postotak bolesnika koji su primali Xoterna Breezhaler odgovorio je s klinički značajnim poboljšanjem rezultata SGRQ-a (definiranim kao smanjenje od najmanje 4 jedinice u odnosu na početnu vrijednost) u 26 tjednu u usporedbi s placebom (63,7% odnosno 56,6%, p=0,088) i tiotropijem (63,7% Xoterna Breezhaler naspram 56,4% tiotropij, p=0,047), u 64 tjednu u usporedbi s glikopironijem i tiotropijem (57,3% Xoterna Breezhaler naspram 51,8% glikopironij, p=0,055; naspram 50,8% tiotropij, p=0,051) i u 52. tjednu u usporedbi s flutikazonom/salmeterolom (49,2% Xoterna Breezhaler naspram 43,7% flutikazon/salmeterol, omjer izgleda: 1,30, p<0,001).
English: Xoterna Breezhaler 85 micrograms/43 micrograms inhalation powder, hard capsules are transparent and yellow and contain a white to almost white powder.
Croatian: Kako Xoterna Breezhaler izgleda i sadržaj pakiranja Xoterna Breezhaler 85 mikrograma/43 mikrograma prašak inhalata, tvrde kapsule su bezbojne i žute i sadrže bijeli do gotovo bijeli prašak.
English: The number of moderate or severe COPD exacerbations/patient-years was 0.94 for Xoterna Breezhaler (812 events), 1.07 for glycopyrronium (900 events) and 1.06 for tiotropium (898 events).
Croatian: Broj umjerenih ili teških egzacerbacija KOPB-a po bolesniku-godini bio je 0,94 za Xoterna Breezhaler (812 događaja), 1,07 za glikopironij (900 događaja) i 1,06 za tiotropij (898 događaja).
English: Xoterna Breezhaler 85 mcg/43 mcg inhalation powder indacaterol/glycopyrronium
Croatian: Xoterna Breezhaler 85 μg/43 μg prašak inhalata indakaterol/glikopironij
English: Steady-state exposure to glycopyrronium after Xoterna Breezhaler inhalation was similar to systemic exposure after glycopyrronium monotherapy product inhalation.
Croatian: Izloženost glikopironiju u stanju dnamičke ravnoteže nakon inhalacije Xoterna Breezhalera bila je slična sistemskoj izloženosti nakon inhalacije monoterapije glikopironijem.
English: How long to continue your treatment with Xoterna Breezhaler Keep using Xoterna Breezhaler for as long as your doctor tells you.
Croatian: Nastavite primijenjivati Xoterna Breezhaler dokle god Vam liječnik kaže.
English: The number of moderate or severe COPD exacerbations/patient-years was 0.98 for Xoterna Breezhaler (1,265 events) and 1.19 for fluticasone/salmeterol (1,452 events).
Croatian: Broj umjerenih ili teških egzacerbacija KOPB-a/bolesnikgodine bio je 0,98 za Xoterna Breezhaler (1265 događaja) i 1,19 za flutikazon/salmeterol (1452 događaja).
English: The mean pre-dose FEV1 (average of the values taken at -45 and -15 minutes prior to the morning dose of study medication) was statistically significant in favour of Xoterna Breezhaler at week 26 compared to fluticasone/salmeterol (least squares [LS] mean treatment difference 100 ml, p<0.001), at week 52 compared to placebo (LS mean treatment difference 189 ml, p<0.001) and at all visits up to week 64 compared to glycopyrronium (LS mean treatment difference 70-80 ml, p<0.001) and tiotropium (LS mean treatment difference 60-80 ml, p<0.001).
Croatian: Srednji FEV1 prije primjene doze (prosjek vrijednosti izmjerenih -45 i -15 minuta prije jutarnje doze ispitivanog lijeka) bio je statistički značajan u korist Xoterna Breezhalera u 26 tjednu u usporedbi s flutikazonom/salmeterolom (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata 100 ml, p<0,001), u 52 tjednu u usporedbi s placebom (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata 189 ml, p<0,001) i na svim posjetima do 64. tjedna u usporedbi s glikopironijem (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata 70-80 ml, p<0,001) i tiotropijem (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata 60-80 ml, p <0,001).
English: Xoterna Breezhaler can be used at the recommended dose in patients with mild and moderate hepatic impairment.
Croatian: Xoterna Breezhaler se može koristiti u preporučenoj dozi u bolesnika s blagim i umjerenim oštećenjem jetre.
English: Xoterna Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
Croatian: Xoterna Breezhaler 85 mikrograma/43 mikrograma, prašak inhalata, tvrde kapsule
English: Xoterna Breezhaler - indacaterol
Croatian: Xoterna Breezhaler - indakaterol
English: Xoterna Breezhaler - tiotropium
Croatian: Xoterna Breezhaler - tiotropij
English: Xoterna Breezhaler 85 micrograms/43 micrograms inhalation powder, hard capsules indacaterol/glycopyrronium
Croatian: Xoterna Breezhaler 85 mikrograma/43 mikrograma prašak inhalata, tvrde kapsule indakaterol/glikopironij
English: During long-term clinical studies, more patients on Xoterna Breezhaler experienced clinically notable changes in blood glucose (4.9%) at the recommended dose than on placebo (2.7%).
Croatian: Tijekom dugoročnih kliničkih ispitivanja, više je bolesnika koji su koristili Xoterna Breezhaler imalo klinički značajne promjene glukoze u krvi (4,9%) u preporučenoj dozi nego onih koji su primali placebo (2,7%). Xoterna Breezhaler se nije ispitivao u bolesnika s loše kontroliranom šećernom bolešću pa se u takvih bolesnika savjetuje oprez i odgovarajuće praćenje.
English: 6 or 10 Xoterna Breezhaler capsules to be used in the inhaler
Croatian: • Jednu ili više blister kartica, od kojih svaka sadrži 6 ili 10 Xoterna Breezhaler kapsula za korištenje u inhalatoru
English: During treatment with Xoterna Breezhaler - Stop using this medicine and seek medical help immediately if you experience any of the following: eye pain or discomfort, temporary blurring of vision, visual halos or coloured images in association with red eyes - these may be signs of an acute attack of narrow-angle glaucoma.
Croatian: - Prestanite uzimati ovaj lijek i odmah potražite medicinsku pomoć ako osjetite nešto od sljedećeg: bol ili nelagoda u oku, privremeno zamagljenje vida, aureole oko izvora svjetlosti ili obojane slike zajedno s crvenim očima - to bi mogli biti znakovi akutnog napada glaukoma uskog kuta. otežano disanje ili gutanje, oticanje jezika, usana ili lica, kožni osip, svrbež i koprivnjača (znakovi alergijske reakcije). stezanje u prsnom košu, kašljanje, piskanje ili nedostatak zraka odmah nakon primjene ovog lijeka - to mogu biti znaci stanja koje se naziva paradoksalni bronhospazam.
English: Xoterna Breezhaler can be used at the recommended dose in patients with mild to moderate renal impairment.
Croatian: Xoterna Breezhaler se može koristiti u preporučenoj dozi u bolesnika s blagim do umjerenim oštećenjem bubrega.
English: What Xoterna Breezhaler is
Croatian: Što je Xoterna Breezhaler
English: SIA „Novartis Baltics“ Lietuvos filialas Tel: +370 5 269 16 50
Croatian: Lietuva SIA „Novartis Baltics“ Lietuvos filialasTel: +370 5
English: Each inhaler should be disposed of after all capsules have been used.
Croatian: Odlaganje inhalatora nakon uporabe Svaki inhalator treba odložiti nakon što ste iskoristili sve kapsule.
English: How much Xoterna Breezhaler to use
Croatian: Koliko Xoterna Breezhalera primjenjivati
English: When to inhale Xoterna Breezhaler
Croatian: Kada inhalirati Xoterna Breezhaler
English: Xoterna Breezhaler has also shown a statistically significant effect on health-related quality of life measured using the St. George's Respiratory Questionnaire (SGRQ) as indicated by a reduction in SGRQ total score at 26 weeks compared to placebo (LS mean treatment difference -3.01, p=0.002) and tiotropium (LS mean treatment difference -2.13, p=0.009) and reductions versus indacaterol and glycopyrronium were -1.09 and -1.18, respectively.
Croatian: St. George's Respiratory Questionnaire, SGRQ) na što upućuje smanjenje u ukupnom rezultatu na SGRQ-u u 26 tjedanu u usporedbi s placebom (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata -3,01, p=0,002) i tiotropijem (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata -2,13, p=0,009) i smanjenje naspram indakaterola i glikopironija bila su -1,09 odnosno -1,18.
English: Xoterna Breezhaler statistically significantly reduced breathlessness as evaluated by the Transitional Dyspnoea Index (TDI); it demonstrated a statistically significant improvement in the TDI focal score at week 26 compared to placebo (LS mean treatment difference 1.09, p<0.001), tiotropium (LS mean treatment difference 0.51, p=0.007) and fluticasone/salmeterol (LS mean treatment difference 0.76, p=0.003).
Croatian: Transitional Dyspnoea Index, TDI); pokazao je statistički značajno poboljšanje u TDI fokalnom rezultatu u 26. tjednu u usporedbi s placebom (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata 1,09, p<0,001), tiotropijem (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata 0,51, p=0,007) i flutikazonom/salmeterolom (srednja vrijednost terapijske razlike dobivena metodom najmanjih kvadrata 0,76, p=0,003).
English: What Xoterna Breezhaler is used for
Croatian: Za što se koristi Xoterna Breezhaler
English: How to store Xoterna Breezhaler
Croatian: Kako čuvati Xoterna Breezhaler
English: How to use Xoterna Breezhaler
Croatian: Kako primjenjivati Xoterna Breezhaler
English: In particular, please tell your doctor or pharmacist if you are using: - any medicines that may be similar to Xoterna Breezhaler (contain similar active substances).
Croatian: Posebno Vas molimo da obavijestite svog liječnika ili ljekarnika ako uzimate: - bilo koji lijek koji može biti sličan Xoterna Breezhaleru (sadrži slične djelatne tvari). - lijekove zvane beta blokatori koji se mogu koristiti za visoki krvni tlak ili druge srčane probleme (kao što je propranolol), ili za problem s očima koji se zove glaukom (kao što je timolol). - lijekove koji snižavaju količinu kalija u Vašoj krvi.
English: - Dispose of the inhaler ineach pack after all capsules in that pack have been used.
Croatian: - Bacite inhalator iz svakog pakiranja nakon što su sve kapsule u tom pakiranju iskorištene.
English: Xoterna Breezhaler - glycopyrronium
Croatian: Xoterna Breezhaler - glikopironij
English: (same class) to those in Xoterna Breezhaler (see section “Other medicines and Xoterna
Croatian: - ako uzimate bilo koji lijek za plućnu bolest koji sadrži djelatne tvari koje su slične (iz iste skupine) kao i one u Xoterna Breezhaleru (pogledajte dio „Drugi lijekovi i Xoterna
English: 5 ml (2.4 mg/ml) 1 vial
Croatian: 5 ml (2,4 mg/ml) 1 bočica
English: 12 mg Solution for injection
Croatian: 12 mg Otopina za injekciju
English: Intrathecal use Vial (glass)
Croatian: Bočica (staklo)
English: Strength Pharmaceutical Form
Croatian: Broj (EU) odobrenja (Zaštićeno) ime Doza Farmaceutski oblik Put primjene Pakiranje
English: Pack size
Croatian: Intratekalno
English: Food and drink
Croatian: Hrana i piće
English: This will result in a loss of medicine.
Croatian: To će dovesti do gubitka lijeka.
English: Gender and body weight
Croatian: Spol i tjelesna težina
English: Talk with your doctor about suitable methods of contraception.
Croatian: Razgovarajte s liječnikom o prikladnim metodama kontracepcije.
English: Dissociation (26%) was one of the most common psychological effects of esketamine.
Croatian: Disocijacija (26%) je bila jedan od najčešćih psihičkih učinaka esketamina.
English: Next device (if required)
Croatian: Sljedeći sprej (ako je potreban)
English: 24 hours Week 1 Week 2 Week 3 Week 4 Week 4
Croatian: 24 sata 1. tjedan 2. tjedan 3. tjedan 4. tjedan 4. tjedan
English: ● increased sensitivity to noise or sounds
Croatian: • povećana osjetljivost na buku ili zvukove
English: It is general clinical experience that the risk of suicide may increase in the early stages of recovery.
Croatian: Opće kliničko iskustvo pokazuje da se rizik od samoubojstva može povećati u ranim fazama oporavka.
English: Subgroup analyses suggest limited efficacy in the population over 75 years old.
Croatian: Analize podskupina ukazuju na ograničenu djelotvornost u populaciji bolesnika starijih od 75 godina.
English: Number of patients (%) Response rate
Croatian: Broj bolesnika (%) Stopa odgovora
English: This leaflet was last revised in {MM/YYYY} OR {month YYYY}.
Croatian: Ova uputa je zadnji puta revidirana u {MM/GGGG} ILI {mjesec GGGG}.
English: The clinical significance of these non-clinical findings in not known.
Croatian: Klinički značaj tih nekliničkih nalaza nije poznat.
English: • Risk factors/groups/ signs of abuse and dependence, which should be regularly assessed and monitored;
Croatian: • koji su faktori rizika/rizične skupine/znakovi zlouporabe i ovisnosti koje treba redovito ocjenjivati i pratiti
English: Therefore, it is unlikely that you will use too much.
Croatian: Stoga nije vjerojatno da ćete primijeniti previše lijeka.
English: You may find it helpful to talk to a relative or a close friend if you are depressed and ask them if they think your depression is getting worse or if they are worried about your behaviour.
Croatian: Možda bi bilo dobro da razgovarate s članom obitelji ili bliskim prijateljem ako ste depresivni te da ih pitate misle li da se Vaša depresija pogoršava i jesu li zabrinuti zbog Vašeg ponašanja.
English: After being treated with this medicine, do not take part in these activities until the next day following a restful sleep.
Croatian: Nakon primjene ovog lijeka nemojte poduzimati takve aktivnosti sve do sljedećega dana, nakon što se dobro naspavate.
English: If you use more Spravato than you should
Croatian: Ako primijenite više lijeka Spravato nego što ste trebali
English: Dose adjustments should be made based on efficacy and tolerability to the previous dose.
Croatian: Dozu treba prilagođavati na temelju djelotvornosti i podnošljivosti prethodne doze.
English: ● feeling disconnected from yourself, your thoughts, feelings and things around you
Croatian: • osjećaj nepovezanosti sa samim sobom, svojim mislima, osjećajima i stvarima oko sebe
English: ● feeling of body temperature change
Croatian: • osjećaj promjene tjelesne temperature
English: The guide for patients also aims at increasing awareness about:
Croatian: Vodič za bolesnike namijenjen je i povećanju svijesti o:
English: AD = antidepressant; NA = not available
Croatian: AD = antidepresiv; ND = nije dostupno
English: Sedation/somnolence
Croatian: Sedacija/somnolencija
English: Revised: {month YYYY}
Croatian: Izmijenjeno: {mjesec GGGG}
English: Depression is associated with an increased risk of suicidal thoughts, self-harm and suicide (suicide-related events).
Croatian: Depresija je povezana s povećanim rizikom od suicidalnih misli, samoozljeđivanja i samoubojstva (suicidalni događaji).
English: ● Breathe in through nose while pushing plunger all the way up until it stops.
Croatian: • udiše kroz nos dok potiskuje klip do kraja, sve dok se ne zaustavi
English: TRD3005 (≥ 65 years)
Croatian: TRD3005 (≥ 65 godina)
English: Especially tell your doctor if you take:
Croatian: Osobito je važno da kažete liječniku ako uzimate:
English: Your doctor will decide if you need 1, 2 or 3 nasal spray devices and how often you should go to the doctor's office or clinic for the medicine.
Croatian: Vaš će liječnik odlučiti trebate li 1, 2 ili 3 spreja za nos i koliko često trebate dolaziti u liječničku ordinaciju ili kliniku radi primjene lijeka.
English: Weeks 5-8:
Croatian: 5. - 8. tjedan:
English: The proportion of the total concentration of esketamine that is bound to proteins in human plasma is on average 43 to 45%.
Croatian: Udio ukupne koncentracije esketamina koji je vezan za proteine u ljudskoj plazmi u prosjeku iznosi 43 - 45%.
English: Other related terms included derealisation (1.9%), depersonalisation (1.7%), illusions (1.5%), and distortion of time (1.2%).
Croatian: Drugi povezani pojmovi uključivali su derealizaciju (1,9%), depersonalizaciju (1,7%), iluzije (1,5%) i poremećaj percepcije vremena (1,2%).
English: ● Check expiration date (‘EXP').
Croatian: • Provjerite rok valjanosti („Rok valjanosti“, „EXP“).
English: Esketamine is the S-enantiomer of racemic ketamine.
Croatian: Esketamin je S-enantiomer racemičnog ketamina.
English: The AUC∞ of esketamine was increased by approximately 29%.
Croatian: AUC∞ esketamina povećao se za približno 29%.
English: Non-clinical data reveal no special hazard for humans based on conventional studies of repeated dose toxicity, genotoxicity, neurotoxicity, reproductive toxicity, and carcinogenic potential.
Croatian: Neklinički podaci ne ukazuju na poseban rizik za ljude na temelju konvencionalnih ispitivanja toksičnosti ponovljenih doza, genotoksičnosti, neurotoksičnosti, reproduktivne toksičnosti i kancerogenog potencijala.
English: Your doctor will take into account the benefit of breast-feeding for you and your child, and the benefit of treatment for you.
Croatian: Ako se bilo što od prethodno navedenoga odnosi na Vas (ili niste sigurni), obratite se svom liječniku prije nego primijenite Spravato.
English: Use in this population is not recommended (see sections 4.4 and 5.2).
Croatian: Ne preporučuje se primjena lijeka u toj populaciji (vidjeti dijelove 4.4 i 5.2).
English: What Spravato is and what it is used for
Croatian: Što je Spravato i za što se koristi
English: ● unusual feeling in the mouth (such as tingling or a crawling feeling)
Croatian: • neobični osjeti u ustima (poput trnaca ili mravinjanja)
English: ● feeling extremely happy (“euphoria”)
Croatian: • osjećaj ekstremne sreće (euforija)
English: The dosing frequency used the majority of the time during the maintenance phase is shown in Table 7.
Croatian: Učestalost primjene koja se koristila većinu vremena tijekom faze održavanja prikazana je u Tablici 7.
English: Other populations at risk
Croatian: Druge rizične populacije
English: In this study, 31.6% of patients received Spravato for greater than 6 months and 7.9% of patients received Spravato for greater than 1 year in the maintenance phase.
Croatian: U ovom je ispitivanju 31,6% bolesnika primalo Spravato dulje od 6 mjeseci, dok je njih 7,9% primalo Spravato dulje od godinu dana u sklopu faze održavanja.
English: Get ready
Croatian: Pripremite se
English: Tell the medical staff right away if your feel like you cannot stay awake or if you feel like you are going to pass out.
Croatian: Odmah recite medicinskom osoblju ako se osjećate kao da ne možete ostati budni ili kao da ćete se onesvijestiti.
English: Tell your doctor or go to the nearest hospital straight away if you have thoughts of harming or killing yourself at any time.
Croatian: Odmah obavijestite svog liječnika ili otiđite u najbližu bolnicu ako u bilo kojem trenutku pomislite na samoozljeđivanje ili samoubojstvo.
English: ● Repeat Step 4 to deliver second spray.
Croatian: • ponovi 4. korak kako bi isporučio drugi potisak
English: ● persistent ringing in the ears (tinnitus)
Croatian: • neprekidna zvonjava u ušima (tinitus)
English: This belongs to a group of medicines called anti-depressants and you have been given this medicine to treat your depression.
Croatian: On pripada skupini lijekova koji se zovu antidepresivi i ovaj ste lijek dobili za liječenje depresije.
English: Depression getting worse
Croatian: Pogoršanje depresije
English: Your doctor or other healthcare professional will show you how to use the nasal spray device (see also Instructions for use).
Croatian: Vaš liječnik ili neki drugi zdravstveni radnik pokazat će Vam kako koristiti sprej za nos (pogledajte i Upute za uporabu).
English: From week 9:
Croatian: Od 9. tjedna nadalje:
English: ● Check indicator again to confirm device is empty.
Croatian: • Ponovno provjerite indikator kako biste se uvjerili da je sprej prazan.
English: These effects did not increase over time and were reversible after discontinuing ketamine.
Croatian: Ti se učinci nisu pojačavali s vremenom i povlačili su se nakon prekida primjene ketamina.
English: It is a non-selective, non-competitive, antagonist of the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor.
Croatian: Radi se o neselektivnom, nekompetitivnom antagonistu N-metil-D-aspartatnog (NMDA) receptora, koji je ionotropni glutamatni receptor.
English: Examples of conditions which should be considered include, but are not limited to:
Croatian: Primjeri stanja koja treba razmotriti uključuju, između ostaloga:
English: These effects may impair attention, judgment, thinking, reaction speed and motor skills.
Croatian: Ti učinci mogu štetno utjecati na pažnju, sposobnost prosuđivanja i razmišljanja, brzinu reagiranja i motoričke sposobnosti.
English: You should avoid eating for 2 hours before treatment and not drinking liquids for 30 minutes before using this medicine.
Croatian: Trebate izbjegavati jesti 2 sata prije primjene i piti tekućinu 30 minuta prije primjene ovog lijeka.
English: ● if you recently had a heart attack (within 6 weeks) This is because Spravato can cause a temporary increase in blood pressure that may lead to serious complications in these conditions.
Croatian: • ako ste nedavno preboljeli srčani udar (unutar 6 tjedana) Naime, Spravato može uzrokovati prolazno povišenje krvnog tlaka, koje kod navedenih stanja može izazvati ozbiljne komplikacije.
English: If your blood pressure goes up after using this medicine and stays high for more than a few hours, you may need to have some more tests.
Croatian: Ako Vam se krvni tlak povisi nakon primjene ovog lijeka i ostane povišen dulje od nekoliko sati, možda će Vam biti potrebne dodatne pretrage.
English: If you are elderly (>65 years), you will be carefully monitored as you may be at increased risk of falling when you start moving around after treatment.
Croatian: Ako ste starija osoba (u dobi od > 65 godina), bit ćete pod pažljivim nadzorom zbog mogućeg povećanog rizika od pada kada se ponovno počnete kretati nakon primjene lijeka.
English: ● feeling detached from reality
Croatian: • osjećaj nepovezanosti sa stvarnošću
English: The decision to prescribe Spravato should be determined by a psychiatrist.
Croatian: Odluku o propisivanju lijeka Spravato treba donijeti psihijatar.
English: IMPORTANT: Ensure that patient waits 5 minutes after each device to allow medicine to absorb.
Croatian: VAŽNO: Pobrinite se da bolesnik pričeka 5 minuta nakon primjene svakog spreja kako bi se lijek apsorbirao.
English: Patients who experience symptoms of a hypertensive crisis should be referred immediately for emergency care.
Croatian: Bolesnike u kojih se jave simptomi hipertenzivne krize treba odmah uputiti na hitno liječenje.